Emily Pimblett serves as Executive at Eliem Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Emily Pimblett has executed 5 insider transactions totaling $18.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 20, 2024 involved selling 1,182 shares valued at $9.7K.
Emily Pimblett currently holds 7,573 shares of Eliem Therapeutics, Inc. (ELYM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Emily Pimblett has been a net seller of ELYM stock. They have purchased $0 and sold $18.7K worth of shares.
Emily Pimblett's most recent insider trade was on Sep 20, 2024, when they sold 1,182 shares at $8.18 per share.
Get notified when new Form 4 filings are submitted
| $8.06 |
| Planned |
| Sep 18, 2024 | ELYM | $0 | Option Exercise | 5,000 | $N/A | Planned |
| Jun 20, 2024 | ELYM | $9.0K | Sale | 1,245 | $7.21 | Discretionary |
| Jun 18, 2024 | ELYM | $0 | Option Exercise | 5,000 | $N/A | Discretionary |